<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/nport" xmlns:com="http://www.sec.gov/edgar/common" xmlns:ncom="http://www.sec.gov/edgar/nportcommon" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sec.gov/edgar/nport eis_NPORT_Filer.xsd">
  <headerData>
    <submissionType>NPORT-P</submissionType>
    <isConfidential>false</isConfidential>
    <filerInfo>
      
      <filer>
        <issuerCredentials>
          <cik>0001414040</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>
      
      
      <seriesClassInfo>
        <seriesId>S000047823</seriesId>
        <classId>C000150206</classId>
      </seriesClassInfo>
      
    </filerInfo>
  </headerData>
  <formData>
    <genInfo>
      <regName>ALPS ETF TRUST</regName>
      <regFileNumber>811-22175</regFileNumber>
      <regCik>0001414040</regCik>
      <regLei>549300VF1907NYC4WM31</regLei>
      <regStreet1>1290 BROADWAY SUITE 1000</regStreet1>
      <regCity>DENVER</regCity>
      <regStateConditional regCountry="US" regState="US-CO"/>
      <regZipOrPostalCode>80203</regZipOrPostalCode>
      <regPhone>3036232577</regPhone>
      <seriesName>ALPS Medical Breakthroughs ETF</seriesName>
      <seriesId>S000047823</seriesId>
      <seriesLei>549300UUE13R3N0UVB96</seriesLei>
      <repPdEnd>2026-11-30</repPdEnd>
      <repPdDate>2026-05-31</repPdDate>
      <isFinalFiling>N</isFinalFiling>
    </genInfo>
    <fundInfo>
      <totAssets>161859852.62</totAssets>
      <totLiabs>67556.42</totLiabs>
      <netAssets>161792296.20</netAssets>
      <assetsAttrMiscSec>0.00000000</assetsAttrMiscSec>
      <assetsInvested>0.00000000</assetsInvested>
      <amtPayOneYrBanksBorr>0.00000000</amtPayOneYrBanksBorr>
      <amtPayOneYrCtrldComp>0.00000000</amtPayOneYrCtrldComp>
      <amtPayOneYrOthAffil>0.00000000</amtPayOneYrOthAffil>
      <amtPayOneYrOther>0.00000000</amtPayOneYrOther>
      <amtPayAftOneYrBanksBorr>0.00000000</amtPayAftOneYrBanksBorr>
      <amtPayAftOneYrCtrldComp>0.00000000</amtPayAftOneYrCtrldComp>
      <amtPayAftOneYrOthAffil>0.00000000</amtPayAftOneYrOthAffil>
      <amtPayAftOneYrOther>0.00000000</amtPayAftOneYrOther>
      <delayDeliv>0.00000000</delayDeliv>
      <standByCommit>0.00000000</standByCommit>
      <liquidPref>0.00000000</liquidPref>
      <cshNotRptdInCorD>0.00000000</cshNotRptdInCorD>
      <borrowers>
        <borrower aggrVal="35374.88000000" lei="VYVVCKR63DVZZN70PB21" name="WELLS FARGO SECURITIES, LLC"/>
        <borrower aggrVal="1645820.17000000" lei="9R7GPTSO7KV3UQJZQ078" name="MORGAN STANLEY &amp; CO. LLC."/>
        <borrower aggrVal="47152.00000000" lei="KB1H1DSPRFMYMCUFXT09" name="WELLS FARGO BANK NATIONAL ASSOCIATION"/>
        <borrower aggrVal="92000.00000000" lei="549300CSX55MXZ47EI78" name="WEDBUSH SECURITIES, INC."/>
        <borrower aggrVal="409471.40000000" lei="5493001I7IJ4CW6Q9N27" name="CITADEL CLEARING LLC"/>
        <borrower aggrVal="3180599.80000000" lei="ZBUT11V806EZRVTWT807" name="JP MORGAN SECURITIES LLC"/>
        <borrower aggrVal="3666228.03000000" lei="549300ZP8XN77GK5BS04" name="CHARLES SCHWAB &amp; .CO., INC."/>
        <borrower aggrVal="201789.36000000" lei="FOR8UP27PHTHYVLBNG30" name="GOLDMAN SACHS &amp; CO. LLC"/>
        <borrower aggrVal="20978916.68000000" lei="549300KUN9K9K32C6D97" name="BNP PARIBAS PRIME BROKERAGE INTERNATIONAL LIMITED"/>
        <borrower aggrVal="1680943.22000000" lei="RCNB6OTYUAMMP879YW96" name="BNP PARIBAS SECURITIES CORPORATION"/>
        <borrower aggrVal="338356.63000000" lei="549300QQRY1JCFQHYS08" name="JANNEY MONTGOMERY SCOTT LLC"/>
        <borrower aggrVal="5354843.22000000" lei="G5GSEF7VJP5I7OUK5573" name="BARCLAYS BANK PLC"/>
        <borrower aggrVal="63090.72000000" lei="549300BLWPABP1VNME36" name="SCOTIA CAPITAL (USA) INC."/>
        <borrower aggrVal="3571.92000000" lei="549300JRHF1MHHWUAW04" name="NATIONAL FINANCIAL SERVICES LLC"/>
        <borrower aggrVal="102340.00000000" lei="BFM8T61CT2L1QCEMIK50" name="UBS AG"/>
      </borrowers>
      <aggregateCondition isNonCashCollateral="Y">
        <aggregateInfos>
          <aggregateInfo amt="26717909.77000000" collatrl="26827114.53000000">
            <invstCat>UST</invstCat>
          </aggregateInfo>
        </aggregateInfos>
      </aggregateCondition>
      <returnInfo>
        <monthlyTotReturns>
          <monthlyTotReturn classId="C000150206" rtn1="1.30000000" rtn2="2.58000000" rtn3="1.42000000"/>
        </monthlyTotReturns>
        <monthlyReturnCats>
          <equityContracts>
            <mon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
            <mon3 netRealizedGain="0.00000000" netUnrealizedAppr="-0.12000000"/>
            <warrantCategory>
              <instrMon1 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon2 netRealizedGain="0.00000000" netUnrealizedAppr="0.00000000"/>
              <instrMon3 netRealizedGain="0.00000000" netUnrealizedAppr="-0.12000000"/>
            </warrantCategory>
          </equityContracts>
        </monthlyReturnCats>
        <othMon1 netRealizedGain="1360141.36000000" netUnrealizedAppr="-249.23000000"/>
        <othMon2 netRealizedGain="1877365.88000000" netUnrealizedAppr="958999.20000000"/>
        <othMon3 netRealizedGain="1983293.46000000" netUnrealizedAppr="249280.65000000"/>
      </returnInfo>
      <mon1Flow redemption="7351074.06000000" reinvestment="0.00000000" sales="0.00000000"/>
      <mon2Flow redemption="1438490.35000000" reinvestment="0.00000000" sales="22154107.23000000"/>
      <mon3Flow redemption="0.00000000" reinvestment="0.00000000" sales="4131032.64000000"/>
      
    </fundInfo>
    <invstOrSecs>
      <invstOrSec>
        <name>Palvella Therapeutics Inc</name>
        <lei>254900AJDH8PAOOI5T33</lei>
        <title>Palvella Therapeutics, Inc.</title>
        <cusip>697947109</cusip>
        <identifiers>
          <isin value="US6979471090"/>
        </identifiers>
        <balance>14096.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1669812.16000000</valUSD>
        <pctVal>1.032071488704</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Immunocore Holdings Plc</name>
        <lei>213800IUE3DFS84BVN18</lei>
        <title>Immunocore Holdings PLC</title>
        <cusip>45258D105</cusip>
        <identifiers>
          <isin value="US45258D1054"/>
        </identifiers>
        <balance>52254.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1509618.06000000</valUSD>
        <pctVal>0.933059296058</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1204799.67000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Novavax Inc</name>
        <lei>529900J4GJHPEPQ23205</lei>
        <title>Novavax, Inc.</title>
        <cusip>670002401</cusip>
        <identifiers>
          <isin value="US6700024010"/>
        </identifiers>
        <balance>167949.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1842400.53000000</valUSD>
        <pctVal>1.138744287133</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1658159.38000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Nuvation Bio Inc</name>
        <lei>N/A</lei>
        <title>Nuvation Bio, Inc.</title>
        <cusip>67080N101</cusip>
        <identifiers>
          <isin value="US67080N1019"/>
        </identifiers>
        <balance>357260.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1707702.80000000</valUSD>
        <pctVal>1.055490799073</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1451169.76000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rigel Pharmaceuticals Inc</name>
        <lei>529900KPTNUS5J8K9K66</lei>
        <title>Rigel Pharmaceuticals, Inc.</title>
        <cusip>766559702</cusip>
        <identifiers>
          <isin value="US7665597024"/>
        </identifiers>
        <balance>19042.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>580590.58000000</valUSD>
        <pctVal>0.358849335621</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="519549.60000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Altimmune Inc</name>
        <lei>549300EOYCQ8SW3NVE64</lei>
        <title>Altimmune, Inc.</title>
        <cusip>02155H200</cusip>
        <identifiers>
          <isin value="US02155H2004"/>
        </identifiers>
        <balance>134076.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>408931.80000000</valUSD>
        <pctVal>0.252751094832</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="294870.95000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alto Neuroscience Inc</name>
        <lei>N/A</lei>
        <title>Alto Neuroscience, Inc.</title>
        <cusip>02157Q109</cusip>
        <identifiers>
          <isin value="US02157Q1094"/>
        </identifiers>
        <balance>32025.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>642741.75000000</valUSD>
        <pctVal>0.397263507037</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Celldex Therapeutics Inc</name>
        <lei>529900F018DMYWH38923</lei>
        <title>Celldex Therapeutics, Inc.</title>
        <cusip>15117B202</cusip>
        <identifiers>
          <isin value="US15117B2025"/>
        </identifiers>
        <balance>68615.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2156569.45000000</valUSD>
        <pctVal>1.332924682232</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Agios Pharmaceuticals Inc</name>
        <lei>529900ONJHY8EOGYT555</lei>
        <title>Agios Pharmaceuticals, Inc.</title>
        <cusip>00847X104</cusip>
        <identifiers>
          <isin value="US00847X1046"/>
        </identifiers>
        <balance>60392.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1775524.80000000</valUSD>
        <pctVal>1.097409976680</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Chinook Therapeutics Inc</name>
        <lei>549300X0O3003W5QYQ48</lei>
        <title>Chinook Therapeutics, Inc.</title>
        <cusip>N/A</cusip>
        <identifiers>
          <ticker value="1835589D"/>
        </identifiers>
        <balance>20700.00000000</balance>
        <units>NC</units>
        <curCd>USD</curCd>
        <valUSD>0.02000000</valUSD>
        <pctVal>0.000000012361</pctVal>
        <payoffProfile>N/A</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>3</fairValLevel>
        <derivativeInfo>
          <optionSwaptionWarrantDeriv derivCat="WAR">
            <counterparties>
              <counterpartyName>Corporate Action</counterpartyName>
              <counterpartyLei>99999999999999999999</counterpartyLei>
            </counterparties>
            <putOrCall>Call</putOrCall>
            <writtenOrPur>Purchased</writtenOrPur>
            <descRefInstrmnt>
              <otherRefInst>
                <issuerName>Chinook Therapeutics, Inc.</issuerName>
                <issueTitle>Chinook Therapeutics, Inc.</issueTitle>
                <identifiers>
                  <cusip value="16961L106"/>
                </identifiers>
              </otherRefInst>
            </descRefInstrmnt>
            <shareNo>1.00000000</shareNo>
            <exercisePrice>0.01000000</exercisePrice>
            <exercisePriceCurCd>USD</exercisePriceCurCd>
            <expDt>2049-12-31</expDt>
            <delta>XXXX</delta>
            <unrealizedAppr>0.02000000</unrealizedAppr>
          </optionSwaptionWarrantDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kymera Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Kymera Therapeutics, Inc.</title>
        <cusip>501575104</cusip>
        <identifiers>
          <isin value="US5015751044"/>
        </identifiers>
        <balance>84154.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6851818.68000000</valUSD>
        <pctVal>4.234947423905</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="5364438.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zura Bio Ltd</name>
        <lei>549300LQXD6M2MIQFN24</lei>
        <title>Zura Bio, Ltd.</title>
        <cusip>G9TY5A101</cusip>
        <identifiers>
          <isin value="KYG9TY5A1016"/>
        </identifiers>
        <balance>88879.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>382179.70000000</valUSD>
        <pctVal>0.236216253169</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="102340.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tarsus Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Tarsus Pharmaceuticals, Inc.</title>
        <cusip>87650L103</cusip>
        <identifiers>
          <isin value="US87650L1035"/>
        </identifiers>
        <balance>43870.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2605878.00000000</valUSD>
        <pctVal>1.610631693352</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mbx Biosciences Inc</name>
        <lei>N/A</lei>
        <title>MBX Biosciences, Inc.</title>
        <cusip>55287L101</cusip>
        <identifiers>
          <isin value="US55287L1017"/>
        </identifiers>
        <balance>46286.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1456620.42000000</valUSD>
        <pctVal>0.900302705512</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="213744.24000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ideaya Biosciences Inc</name>
        <lei>549300ULW08F62IJML11</lei>
        <title>Ideaya Biosciences, Inc.</title>
        <cusip>45166A102</cusip>
        <identifiers>
          <isin value="US45166A1025"/>
        </identifiers>
        <balance>90520.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2667624.40000000</valUSD>
        <pctVal>1.648795685983</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Omniab Inc</name>
        <lei>N/A</lei>
        <title>OmniAb, Inc.</title>
        <cusip>68218J301</cusip>
        <identifiers>
          <isin value="US68218J3014"/>
        </identifiers>
        <balance>3653.00000000</balance>
        <units>NC</units>
        <curCd>USD</curCd>
        <valUSD>0.00000000</valUSD>
        <pctVal>0.000000</pctVal>
        <payoffProfile>N/A</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>3</fairValLevel>
        <derivativeInfo>
          <optionSwaptionWarrantDeriv derivCat="WAR">
            <counterparties>
              <counterpartyName>Corporate Action</counterpartyName>
              <counterpartyLei>99999999999999999999</counterpartyLei>
            </counterparties>
            <putOrCall>Call</putOrCall>
            <writtenOrPur>Purchased</writtenOrPur>
            <descRefInstrmnt>
              <otherRefInst>
                <issuerName>OmniAb Inc</issuerName>
                <issueTitle>OmniAb Inc</issueTitle>
                <identifiers>
                  <cusip value="68218J103"/>
                </identifiers>
              </otherRefInst>
            </descRefInstrmnt>
            <shareNo>1.00000000</shareNo>
            <exercisePrice>0.01000000</exercisePrice>
            <exercisePriceCurCd>USD</exercisePriceCurCd>
            <expDt>2049-12-31</expDt>
            <delta>XXXX</delta>
            <unrealizedAppr>0.00000000</unrealizedAppr>
          </optionSwaptionWarrantDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Moonlake Immunotherapeutics</name>
        <lei>N/A</lei>
        <title>MoonLake Immunotherapeutics</title>
        <cusip>61559X104</cusip>
        <identifiers>
          <isin value="KY61559X1045"/>
        </identifiers>
        <balance>73934.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1418054.12000000</valUSD>
        <pctVal>0.876465785643</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bicycle Therapeutics Plc</name>
        <lei>213800XKUI6R7GKC3E43</lei>
        <title>Bicycle Therapeutics PLC</title>
        <cusip>088786108</cusip>
        <identifiers>
          <isin value="US0887861088"/>
        </identifiers>
        <balance>51450.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>241300.50000000</valUSD>
        <pctVal>0.149142144383</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>GB</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Relay Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Relay Therapeutics, Inc.</title>
        <cusip>75943R102</cusip>
        <identifiers>
          <isin value="US75943R1023"/>
        </identifiers>
        <balance>184224.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2588347.20000000</valUSD>
        <pctVal>1.599796319597</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zai Lab Ltd</name>
        <lei>549300P2UYQ9U5LY1T58</lei>
        <title>Zai Lab, Ltd.</title>
        <cusip>98887Q104</cusip>
        <identifiers>
          <isin value="US98887Q1040"/>
        </identifiers>
        <balance>115031.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2034898.39000000</valUSD>
        <pctVal>1.257722671470</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1829835.91000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aardvark Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Aardvark Therapeutics, Inc.</title>
        <cusip>002942100</cusip>
        <identifiers>
          <isin value="US0029421007"/>
        </identifiers>
        <balance>22439.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>92224.29000000</valUSD>
        <pctVal>0.057001657165</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Bicara Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Bicara Therapeutics, Inc.</title>
        <cusip>055477103</cusip>
        <identifiers>
          <isin value="US0554771032"/>
        </identifiers>
        <balance>65313.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1420557.75000000</valUSD>
        <pctVal>0.878013220261</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Lakefront Biotherapeutics Nv</name>
        <lei>549300QKJ78IY0IOV655</lei>
        <title>Lakefront Biotherapeutics NV</title>
        <cusip>36315X101</cusip>
        <identifiers>
          <isin value="US36315X1019"/>
        </identifiers>
        <balance>67945.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1926240.75000000</valUSD>
        <pctVal>1.190563948495</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>BE</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="62370.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rapport Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Rapport Therapeutics, Inc.</title>
        <cusip>75383L102</cusip>
        <identifiers>
          <isin value="US75383L1026"/>
        </identifiers>
        <balance>49264.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1945928.00000000</valUSD>
        <pctVal>1.202732173103</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="440583.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Stoke Therapeutics Inc</name>
        <lei>549300RD25SS2DIJHJ67</lei>
        <title>Stoke Therapeutics, Inc.</title>
        <cusip>86150R107</cusip>
        <identifiers>
          <isin value="US86150R1077"/>
        </identifiers>
        <balance>58873.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1819764.43000000</valUSD>
        <pctVal>1.124753447933</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Protara Therapeutics Inc</name>
        <lei>549300VWUGH3220TG273</lei>
        <title>Protara Therapeutics, Inc.</title>
        <cusip>74365U107</cusip>
        <identifiers>
          <isin value="US74365U1079"/>
        </identifiers>
        <balance>55748.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>259228.20000000</valUSD>
        <pctVal>0.160222832661</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Crinetics Pharmaceuticals Inc</name>
        <lei>549300Q1CNFXK5P31D28</lei>
        <title>Crinetics Pharmaceuticals, Inc.</title>
        <cusip>22663K107</cusip>
        <identifiers>
          <isin value="US22663K1079"/>
        </identifiers>
        <balance>107892.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3835560.60000000</valUSD>
        <pctVal>2.370669488032</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3310664.85000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Forte Biosciences Inc</name>
        <lei>529900Z84WFDHPS3JP76</lei>
        <title>Forte Biosciences, Inc.</title>
        <cusip>34962G208</cusip>
        <identifiers>
          <isin value="US34962G2084"/>
        </identifiers>
        <balance>12912.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>246231.84000000</valUSD>
        <pctVal>0.152190089258</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sionna Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Sionna Therapeutics, Inc.</title>
        <cusip>829401108</cusip>
        <identifiers>
          <isin value="US8294011080"/>
        </identifiers>
        <balance>46379.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1985948.78000000</valUSD>
        <pctVal>1.227468072735</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kalvista Pharmaceuticals Inc</name>
        <lei>529900Q7IDA3WUGRZA51</lei>
        <title>KalVista Pharmaceuticals, Inc.</title>
        <cusip>483497103</cusip>
        <identifiers>
          <isin value="US4834971032"/>
        </identifiers>
        <balance>52105.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1400061.35000000</valUSD>
        <pctVal>0.865344879133</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arrivent Biopharma Inc</name>
        <lei>N/A</lei>
        <title>ArriVent Biopharma, Inc.</title>
        <cusip>04272N102</cusip>
        <identifiers>
          <isin value="US04272N1028"/>
        </identifiers>
        <balance>45563.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1379192.01000000</valUSD>
        <pctVal>0.852446032594</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Pharvaris Nv</name>
        <lei>9845003BE146D3B75D32</lei>
        <title>Pharvaris NV</title>
        <cusip>N69605108</cusip>
        <identifiers>
          <isin value="NL00150005Y4"/>
        </identifiers>
        <balance>66026.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1991344.16000000</valUSD>
        <pctVal>1.230802829782</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Neurogene Inc</name>
        <lei>529900A7VIY892SZVW73</lei>
        <title>Neurogene, Inc.</title>
        <cusip>64135M105</cusip>
        <identifiers>
          <isin value="US64135M1053"/>
        </identifiers>
        <balance>15968.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>452533.12000000</valUSD>
        <pctVal>0.279700041737</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Compass Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Compass Therapeutics, Inc.</title>
        <cusip>20454B104</cusip>
        <identifiers>
          <isin value="US20454B1044"/>
        </identifiers>
        <balance>185633.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>441806.54000000</valUSD>
        <pctVal>0.273070195785</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Amylyx Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Amylyx Pharmaceuticals, Inc.</title>
        <cusip>03237H101</cusip>
        <identifiers>
          <isin value="US03237H1014"/>
        </identifiers>
        <balance>113933.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1634938.55000000</valUSD>
        <pctVal>1.010516933376</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Spyre Therapeutics Inc</name>
        <lei>52990017AIJPRH3HQH40</lei>
        <title>Spyre Therapeutics, Inc.</title>
        <cusip>00773J202</cusip>
        <identifiers>
          <isin value="US00773J2024"/>
        </identifiers>
        <balance>80958.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5950413.00000000</valUSD>
        <pctVal>3.677809846177</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3895500.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Newamsterdam Pharma Co Nv</name>
        <lei>984500B6549TF6E14D36</lei>
        <title>Newamsterdam Pharma Co. NV</title>
        <cusip>N62509109</cusip>
        <identifiers>
          <isin value="NL00150012L7"/>
        </identifiers>
        <balance>118514.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3991551.52000000</valUSD>
        <pctVal>2.467083794314</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="478188.64000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Novo Nordisk A/s</name>
        <lei>549300DAQ1CVT6CXN342</lei>
        <title>Novo Nordisk A/S</title>
        <cusip>N/A</cusip>
        <identifiers>
          <ticker value="2600057D"/>
        </identifiers>
        <balance>1233.00000000</balance>
        <units>NC</units>
        <curCd>USD</curCd>
        <valUSD>0.00000000</valUSD>
        <pctVal>0.000000</pctVal>
        <payoffProfile>N/A</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>DK</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>2</fairValLevel>
        <derivativeInfo>
          <optionSwaptionWarrantDeriv derivCat="WAR">
            <counterparties>
              <counterpartyName>Corporate Action</counterpartyName>
              <counterpartyLei>99999999999999999999</counterpartyLei>
            </counterparties>
            <putOrCall>Call</putOrCall>
            <writtenOrPur>Purchased</writtenOrPur>
            <descRefInstrmnt>
              <otherRefInst>
                <issuerName>Novo Nordisk A/S</issuerName>
                <issueTitle>Novo Nordisk A/S</issueTitle>
                <identifiers>
                  <cusip value="00973Y108"/>
                </identifiers>
              </otherRefInst>
            </descRefInstrmnt>
            <shareNo>1.00000000</shareNo>
            <exercisePrice>0.01000000</exercisePrice>
            <exercisePriceCurCd>USD</exercisePriceCurCd>
            <expDt>2049-12-31</expDt>
            <delta>XXXX</delta>
            <unrealizedAppr>0.00000000</unrealizedAppr>
          </optionSwaptionWarrantDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Zenas Biopharma Inc</name>
        <lei>N/A</lei>
        <title>Zenas Biopharma, Inc.</title>
        <cusip>98937L105</cusip>
        <identifiers>
          <isin value="US98937L1052"/>
        </identifiers>
        <balance>55332.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1018108.80000000</valUSD>
        <pctVal>0.629269022019</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="901563.20000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Aclaris Therapeutics Inc</name>
        <lei>5493000B2LQ9QTW1DF52</lei>
        <title>Aclaris Therapeutics, Inc.</title>
        <cusip>00461U105</cusip>
        <identifiers>
          <isin value="US00461U1051"/>
        </identifiers>
        <balance>124304.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>565583.20000000</valUSD>
        <pctVal>0.349573628215</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Fulgent Genetics Inc</name>
        <lei>549300CL6P01M68QJ404</lei>
        <title>Fulgent Genetics, Inc.</title>
        <cusip>359664109</cusip>
        <identifiers>
          <isin value="US3596641098"/>
        </identifiers>
        <balance>32191.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>583944.74000000</valUSD>
        <pctVal>0.360922462759</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="472383.74000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mannkind Corp</name>
        <lei>213800GFBCNY1ZFST722</lei>
        <title>MannKind Corp.</title>
        <cusip>56400P706</cusip>
        <identifiers>
          <isin value="US56400P7069"/>
        </identifiers>
        <balance>317578.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1197269.06000000</valUSD>
        <pctVal>0.740003750561</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Upstream Bio Inc</name>
        <lei>N/A</lei>
        <title>Upstream Bio, Inc.</title>
        <cusip>91678A107</cusip>
        <identifiers>
          <isin value="US91678A1079"/>
        </identifiers>
        <balance>55699.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>465643.64000000</valUSD>
        <pctVal>0.287803344742</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Design Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Design Therapeutics, Inc.</title>
        <cusip>25056L103</cusip>
        <identifiers>
          <isin value="US25056L1035"/>
        </identifiers>
        <balance>63568.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>666192.64000000</valUSD>
        <pctVal>0.411757948707</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="599456.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Celcuity Inc</name>
        <lei>25490070W7UU7W2SEY87</lei>
        <title>Celcuity, Inc.</title>
        <cusip>15102K100</cusip>
        <identifiers>
          <isin value="US15102K1007"/>
        </identifiers>
        <balance>47693.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6337445.84000000</valUSD>
        <pctVal>3.917025710646</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="2949936.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vanda Pharmaceuticals Inc</name>
        <lei>529900AY8VOOQBKJ0O70</lei>
        <title>Vanda Pharmaceuticals, Inc.</title>
        <cusip>921659108</cusip>
        <identifiers>
          <isin value="US9216591084"/>
        </identifiers>
        <balance>60925.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>392966.25000000</valUSD>
        <pctVal>0.242883165162</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="259290.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Astrazeneca Plc</name>
        <lei>PY6ZZQWO2IZFZC3IOL08</lei>
        <title>AstraZeneca PLC</title>
        <cusip>N/A</cusip>
        <identifiers>
          <ticker value="2334482D"/>
        </identifiers>
        <balance>36586.00000000</balance>
        <units>NC</units>
        <curCd>USD</curCd>
        <valUSD>0.04000000</valUSD>
        <pctVal>0.000000024723</pctVal>
        <payoffProfile>N/A</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>3</fairValLevel>
        <derivativeInfo>
          <optionSwaptionWarrantDeriv derivCat="WAR">
            <counterparties>
              <counterpartyName>Corporate Action</counterpartyName>
              <counterpartyLei>99999999999999999999</counterpartyLei>
            </counterparties>
            <putOrCall>Call</putOrCall>
            <writtenOrPur>Purchased</writtenOrPur>
            <descRefInstrmnt>
              <otherRefInst>
                <issuerName>AstraZeneca PLC</issuerName>
                <issueTitle>AstraZeneca PLC</issueTitle>
                <identifiers>
                  <cusip value="046353108"/>
                </identifiers>
              </otherRefInst>
            </descRefInstrmnt>
            <shareNo>1.00000000</shareNo>
            <exercisePrice>0.01000000</exercisePrice>
            <exercisePriceCurCd>USD</exercisePriceCurCd>
            <expDt>2099-12-31</expDt>
            <delta>XXXX</delta>
            <unrealizedAppr>0.04000000</unrealizedAppr>
          </optionSwaptionWarrantDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Sarepta Therapeutics Inc</name>
        <lei>549300IKDPIED8J8IG21</lei>
        <title>Sarepta Therapeutics, Inc.</title>
        <cusip>803607100</cusip>
        <identifiers>
          <isin value="US8036071004"/>
        </identifiers>
        <balance>108222.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1933927.14000000</valUSD>
        <pctVal>1.195314724756</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vera Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Vera Therapeutics, Inc.</title>
        <cusip>92337R101</cusip>
        <identifiers>
          <isin value="US92337R1014"/>
        </identifiers>
        <balance>73552.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2612567.04000000</valUSD>
        <pctVal>1.614766031115</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="487476.48000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tyra Biosciences Inc</name>
        <lei>N/A</lei>
        <title>Tyra Biosciences, Inc.</title>
        <cusip>90240B106</cusip>
        <identifiers>
          <isin value="US90240B1061"/>
        </identifiers>
        <balance>55509.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1854555.69000000</valUSD>
        <pctVal>1.146257104669</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="395507.58000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Candel Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Candel Therapeutics, Inc.</title>
        <cusip>137404109</cusip>
        <identifiers>
          <isin value="US1374041093"/>
        </identifiers>
        <balance>75500.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>626650.00000000</valUSD>
        <pctVal>0.387317576125</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="441020.50000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mirum Pharmaceuticals Inc</name>
        <lei>254900YZKR40F7F27K81</lei>
        <title>Mirum Pharmaceuticals, Inc.</title>
        <cusip>604749101</cusip>
        <identifiers>
          <isin value="US6047491013"/>
        </identifiers>
        <balance>62199.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6313198.50000000</valUSD>
        <pctVal>3.902039002027</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Maze Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Maze Therapeutics, Inc.</title>
        <cusip>578784100</cusip>
        <identifiers>
          <isin value="US5787841007"/>
        </identifiers>
        <balance>49602.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1312468.92000000</valUSD>
        <pctVal>0.811206065323</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="513482.76000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Disc Medicine Inc</name>
        <lei>N/A</lei>
        <title>Disc Medicine, Inc.</title>
        <cusip>254604101</cusip>
        <identifiers>
          <isin value="US2546041011"/>
        </identifiers>
        <balance>39334.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2736466.38000000</valUSD>
        <pctVal>1.691345289158</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="115138.35000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oruka Therapeutics Inc</name>
        <lei>529900TG7O4ESUDMGI54</lei>
        <title>Oruka Therapeutics, Inc.</title>
        <cusip>687604108</cusip>
        <identifiers>
          <isin value="US6876041087"/>
        </identifiers>
        <balance>49896.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2920412.88000000</valUSD>
        <pctVal>1.805038279690</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="1178208.90000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Tectonic Therapeutic Inc</name>
        <lei>N/A</lei>
        <title>Tectonic Therapeutic, Inc.</title>
        <cusip>878972108</cusip>
        <identifiers>
          <isin value="US8789721086"/>
        </identifiers>
        <balance>19353.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>603136.25000000</valUSD>
        <pctVal>0.372784282172</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="397603.07000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Viking Therapeutics Inc</name>
        <lei>529900IVC72YPFA25M37</lei>
        <title>Viking Therapeutics, Inc.</title>
        <cusip>92686J106</cusip>
        <identifiers>
          <isin value="US92686J1060"/>
        </identifiers>
        <balance>119108.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3899595.92000000</valUSD>
        <pctVal>2.410248208097</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Omniab Inc</name>
        <lei>N/A</lei>
        <title>OmniAb, Inc.</title>
        <cusip>68218J202</cusip>
        <identifiers>
          <isin value="US68218J2024"/>
        </identifiers>
        <balance>3653.00000000</balance>
        <units>NC</units>
        <curCd>USD</curCd>
        <valUSD>0.00000000</valUSD>
        <pctVal>0.000000</pctVal>
        <payoffProfile>N/A</payoffProfile>
        <assetCat>DE</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>3</fairValLevel>
        <derivativeInfo>
          <optionSwaptionWarrantDeriv derivCat="WAR">
            <counterparties>
              <counterpartyName>Corporate Action</counterpartyName>
              <counterpartyLei>99999999999999999999</counterpartyLei>
            </counterparties>
            <putOrCall>Call</putOrCall>
            <writtenOrPur>Purchased</writtenOrPur>
            <descRefInstrmnt>
              <otherRefInst>
                <issuerName>OmniAb Inc</issuerName>
                <issueTitle>OmniAb Inc</issueTitle>
                <identifiers>
                  <cusip value="68218J103"/>
                </identifiers>
              </otherRefInst>
            </descRefInstrmnt>
            <shareNo>1.00000000</shareNo>
            <exercisePrice>0.01000000</exercisePrice>
            <exercisePriceCurCd>USD</exercisePriceCurCd>
            <expDt>2049-12-31</expDt>
            <delta>XXXX</delta>
            <unrealizedAppr>0.00000000</unrealizedAppr>
          </optionSwaptionWarrantDeriv>
        </derivativeInfo>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Cg Oncology Inc</name>
        <lei>N/A</lei>
        <title>CG oncology, Inc.</title>
        <cusip>156944100</cusip>
        <identifiers>
          <isin value="US1569441009"/>
        </identifiers>
        <balance>87032.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>5421223.28000000</valUSD>
        <pctVal>3.350730169067</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="3309654.57000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Edgewise Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Edgewise Therapeutics, Inc.</title>
        <cusip>28036F105</cusip>
        <identifiers>
          <isin value="US28036F1057"/>
        </identifiers>
        <balance>110576.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3777276.16000000</valUSD>
        <pctVal>2.334645251174</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Anavex Life Sciences Corp</name>
        <lei>549300K1I5L8COCQ8W36</lei>
        <title>Anavex Life Sciences Corp.</title>
        <cusip>032797300</cusip>
        <identifiers>
          <isin value="US0327973006"/>
        </identifiers>
        <balance>95522.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>289431.66000000</valUSD>
        <pctVal>0.178890878489</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="31512.00000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Akebia Therapeutics Inc</name>
        <lei>549300CBQEHMKEEGNX42</lei>
        <title>Akebia Therapeutics, Inc.</title>
        <cusip>00972D105</cusip>
        <identifiers>
          <isin value="US00972D1054"/>
        </identifiers>
        <balance>276121.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>281643.42000000</valUSD>
        <pctVal>0.174077151146</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>State Street Institutional Treasury Plus Money Market Fund</name>
        <lei>549300PNASLVKQG64331</lei>
        <title>State Street Institutional Treasury Plus Money Market Fund</title>
        <cusip>857492862</cusip>
        <identifiers>
          <isin value="US8574928623"/>
        </identifiers>
        <balance>6739.41000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>6739.41000000</valUSD>
        <pctVal>0.004165470271</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Rezolute Inc</name>
        <lei>549300T05L48T72P2G08</lei>
        <title>Rezolute, Inc.</title>
        <cusip>76200L309</cusip>
        <identifiers>
          <isin value="US76200L3096"/>
        </identifiers>
        <balance>98643.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>325521.90000000</valUSD>
        <pctVal>0.201197404107</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Oculis Holding Ag</name>
        <lei>5067005370C2KK324336</lei>
        <title>Oculis Holding AG</title>
        <cusip>H5870P102</cusip>
        <identifiers>
          <isin value="CH1242303498"/>
        </identifiers>
        <balance>58929.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1354188.42000000</valUSD>
        <pctVal>0.836991903697</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CH</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Kura Oncology Inc</name>
        <lei>5493005QORQTZCZYOP39</lei>
        <title>Kura Oncology, Inc.</title>
        <cusip>50127T109</cusip>
        <identifiers>
          <isin value="US50127T1097"/>
        </identifiers>
        <balance>91050.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>928710.00000000</valUSD>
        <pctVal>0.574013733541</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Apogee Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Apogee Therapeutics, Inc.</title>
        <cusip>03770N101</cusip>
        <identifiers>
          <isin value="US03770N1019"/>
        </identifiers>
        <balance>57722.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4741285.08000000</valUSD>
        <pctVal>2.930476414117</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="182268.66000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Travere Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Travere Therapeutics, Inc.</title>
        <cusip>89422G107</cusip>
        <identifiers>
          <isin value="US89422G1076"/>
        </identifiers>
        <balance>95051.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4484506.18000000</valUSD>
        <pctVal>2.771767435982</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="778375.64000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Olema Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Olema Pharmaceuticals, Inc.</title>
        <cusip>68062P106</cusip>
        <identifiers>
          <isin value="US68062P1066"/>
        </identifiers>
        <balance>81077.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1069405.63000000</valUSD>
        <pctVal>0.660974382042</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Geron Corp</name>
        <lei>549300T282D7Z2YESL90</lei>
        <title>Geron Corp.</title>
        <cusip>374163103</cusip>
        <identifiers>
          <isin value="US3741631036"/>
        </identifiers>
        <balance>660249.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>825311.25000000</valUSD>
        <pctVal>0.510105406366</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Delcath Systems Inc</name>
        <lei>549300NVPLITUM6URT02</lei>
        <title>Delcath Systems, Inc.</title>
        <cusip>24661P807</cusip>
        <identifiers>
          <isin value="US24661P8077"/>
        </identifiers>
        <balance>35814.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>386074.92000000</valUSD>
        <pctVal>0.238623796724</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="325254.16000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xencor Inc</name>
        <lei>549300V5IF65437JKG30</lei>
        <title>Xencor, Inc.</title>
        <cusip>98401F105</cusip>
        <identifiers>
          <isin value="US98401F1057"/>
        </identifiers>
        <balance>75597.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>898092.36000000</valUSD>
        <pctVal>0.555089692830</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="632004.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Alkermes Plc</name>
        <lei>N/A</lei>
        <title>Alkermes PLC</title>
        <cusip>G01767105</cusip>
        <identifiers>
          <isin value="IE00B56GVS15"/>
        </identifiers>
        <balance>171723.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>7244993.37000000</valUSD>
        <pctVal>4.477959420913</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>IE</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Immatics Nv</name>
        <lei>984500DC691EZ96AF394</lei>
        <title>Immatics NV</title>
        <cusip>N44445109</cusip>
        <identifiers>
          <isin value="NL0015285941"/>
        </identifiers>
        <balance>138190.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1590566.90000000</valUSD>
        <pctVal>0.983091863677</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>NL</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Dianthus Therapeutics Inc</name>
        <lei>549300Z3N6ODPCOFC890</lei>
        <title>Dianthus Therapeutics, Inc.</title>
        <cusip>252828108</cusip>
        <identifiers>
          <isin value="US2528281080"/>
        </identifiers>
        <balance>45839.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4263485.39000000</valUSD>
        <pctVal>2.635159701750</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Arcturus Therapeutics Holdings Inc</name>
        <lei>N/A</lei>
        <title>Arcturus Therapeutics Holdings, Inc.</title>
        <cusip>03969T109</cusip>
        <identifiers>
          <isin value="US03969T1097"/>
        </identifiers>
        <balance>29289.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>231968.88000000</valUSD>
        <pctVal>0.143374490286</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="66211.20000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Atea Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>Atea Pharmaceuticals, Inc.</title>
        <cusip>04683R106</cusip>
        <identifiers>
          <isin value="US04683R1068"/>
        </identifiers>
        <balance>82125.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>383523.75000000</valUSD>
        <pctVal>0.237046978754</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Mineralys Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Mineralys Therapeutics, Inc.</title>
        <cusip>603170101</cusip>
        <identifiers>
          <isin value="US6031701013"/>
        </identifiers>
        <balance>81578.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2569707.00000000</valUSD>
        <pctVal>1.588275251884</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Regenxbio Inc</name>
        <lei>549300EOES47LATSET33</lei>
        <title>REGENXBIO, Inc.</title>
        <cusip>75901B107</cusip>
        <identifiers>
          <isin value="US75901B1070"/>
        </identifiers>
        <balance>53200.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>372932.00000000</valUSD>
        <pctVal>0.230500468043</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="128268.98000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Xenon Pharmaceuticals Inc</name>
        <lei>549300XV44Q9Z1MIPQ03</lei>
        <title>Xenon Pharmaceuticals, Inc.</title>
        <cusip>98420N105</cusip>
        <identifiers>
          <isin value="CA98420N1050"/>
        </identifiers>
        <balance>85746.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>4692878.58000000</valUSD>
        <pctVal>2.900557498855</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>CA</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Theravance Biopharma Inc</name>
        <lei>5493007VTSXP4Z6MIW52</lei>
        <title>Theravance Biopharma, Inc.</title>
        <cusip>G8807B106</cusip>
        <identifiers>
          <isin value="KYG8807B1068"/>
        </identifiers>
        <balance>52230.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>838813.80000000</valUSD>
        <pctVal>0.518451013862</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Vericel Corp</name>
        <lei>54930076YM3PLTDR4B91</lei>
        <title>Vericel Corp.</title>
        <cusip>92346J108</cusip>
        <identifiers>
          <isin value="US92346J1088"/>
        </identifiers>
        <balance>52309.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1743458.97000000</valUSD>
        <pctVal>1.077590843908</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Taysha Gene Therapies Inc</name>
        <lei>N/A</lei>
        <title>Taysha Gene Therapies, Inc.</title>
        <cusip>877619106</cusip>
        <identifiers>
          <isin value="US8776191061"/>
        </identifiers>
        <balance>282348.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1657382.76000000</valUSD>
        <pctVal>1.024389169896</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="766903.76000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>N/A</name>
        <lei>N/A</lei>
        <title>SECURITIES LENDING - GENERAL</title>
        <cusip>N/A</cusip>
        <identifiers>
          <ticker value="SECLEND"/>
        </identifiers>
        <balance>0.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>0.00000000</valUSD>
        <pctVal>0.000000</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>STIV</assetCat>
        <issuerCat>RF</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <cashCollateralCondition cashCollateralVal="11763931.00000000" isCashCollateral="Y"/>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Structure Therapeutics Inc</name>
        <lei>N/A</lei>
        <title>Structure Therapeutics, Inc.</title>
        <cusip>86366E106</cusip>
        <identifiers>
          <isin value="US86366E1064"/>
        </identifiers>
        <balance>73020.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>2872606.80000000</valUSD>
        <pctVal>1.775490469860</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>KY</invCountry>
        
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Denali Therapeutics Inc</name>
        <lei>549300ZTQ2HO18L3Q830</lei>
        <title>Denali Therapeutics, Inc.</title>
        <cusip>24823R105</cusip>
        <identifiers>
          <isin value="US24823R1059"/>
        </identifiers>
        <balance>163467.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3439345.68000000</valUSD>
        <pctVal>2.125778396610</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="393027.20000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Ars Pharmaceuticals Inc</name>
        <lei>N/A</lei>
        <title>ARS Pharmaceuticals, Inc.</title>
        <cusip>82835W108</cusip>
        <identifiers>
          <isin value="US82835W1080"/>
        </identifiers>
        <balance>102352.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>928332.64000000</valUSD>
        <pctVal>0.573780496231</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="835492.12000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Corvus Pharmaceuticals Inc</name>
        <lei>549300I3AVJ8F75NCX65</lei>
        <title>Corvus Pharmaceuticals, Inc.</title>
        <cusip>221015100</cusip>
        <identifiers>
          <isin value="US2210151005"/>
        </identifiers>
        <balance>86347.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>1071566.27000000</valUSD>
        <pctVal>0.662309822635</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <loanByFundCondition isLoanByFund="Y" loanVal="814244.92000000"/>
        </securityLending>
      </invstOrSec>
      <invstOrSec>
        <name>Acadia Pharmaceuticals Inc</name>
        <lei>529900O3044NO0PEA039</lei>
        <title>ACADIA Pharmaceuticals, Inc.</title>
        <cusip>004225108</cusip>
        <identifiers>
          <isin value="US0042251084"/>
        </identifiers>
        <balance>175740.00000000</balance>
        <units>NS</units>
        <curCd>USD</curCd>
        <valUSD>3806528.40000000</valUSD>
        <pctVal>2.352725370369</pctVal>
        <payoffProfile>Long</payoffProfile>
        <assetCat>EC</assetCat>
        <issuerCat>CORP</issuerCat>
        <invCountry>US</invCountry>
        <isRestrictedSec>N</isRestrictedSec>
        
        <fairValLevel>1</fairValLevel>
        <securityLending>
          <isCashCollateral>N</isCashCollateral>
          <isNonCashCollateral>N</isNonCashCollateral>
          <isLoanByFund>N</isLoanByFund>
        </securityLending>
      </invstOrSec>
    </invstOrSecs>
    <signature>
      <ncom:dateSigned>2026-06-30</ncom:dateSigned>
      <ncom:nameOfApplicant>ALPS ETF TRUST</ncom:nameOfApplicant>
      <ncom:signature>Erich Rettinger</ncom:signature>
      <ncom:signerName>Erich Rettinger</ncom:signerName>
      <ncom:title>Treasurer</ncom:title>
    </signature>
  </formData>
</edgarSubmission>
